Beyond Air announces sale of 85% of NeuroNOS to XTL Biopharmaceuticals, gaining cash, shares, and milestones, as XAIR stock jumps 165% premarket.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback